Leah Rosenbaum, Forbes Staff

Author's posts

Everything You Need To Know About Johnson & Johnson’s Covid-19 Vaccine

A special committee will meet on Friday to discuss the vaccine; here’s what you need to know.

FDA Docs Show Johnson & Johnson’s One-Shot Covid-19 Vaccine To Be Safe And Effective At Preventing Severe Disease

The agency’s vaccine review committee will meet on Friday to determine whether to endorse authorization of the company’s vaccine.

The U.K., The EU And The WHO Have All Authorized AstraZeneca’s Covid-19 Vaccine —Why Hasn’t The U.S.?

Pundits are urging the FDA to approve the AstraZeneca-Oxford Covid-19 vaccine, but the vaccine has been plagued with complications

One Medical Let People Jump The Line For Covid-19 Vaccines

The healthcare company did not demand identification of vaccine recipients despite state guidelines.

Researchers Estimate There Were 17 Million Undiagnosed Cases Of Covid-19 Last Summer

A new preprint from the National Institutes of Health found that almost 5% of American adults had undiagnosed Covid-19.

Some Experts Claim Covid-19 Reinfections Are ‘Not A Huge Problem’—But Nobody’s Tracking The Numbers

One downside to the U.S.’s lackluster genome sequencing is that the true number of Covid-19 reinfections remains unknown. Here’s why that matters.

A New Coalition Forms To Make Digital Vaccine ID Cards A Reality

More than 10 companies are coming together to make a digital vaccine card for Covid-19.

This Company Raised $40 Million To Make Tumors Reveal Themselves

Biotech company Earli plans to take liquid biopsy to the next level

Moderna Releases Details Of New Vaccine Deals While Novavax Moves To Phase 3

Both companies stand to earn billions as their coronavirus vaccine programs move forward.

Researchers Suggest Prioritizing First Dose Of Covid-19 Vaccine For All — But FDA Not On Board Yet

Despite calls from scientists and doctors, the government agency says it has no plans to stray from the two-dose schedule that was authorized last month.